Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Phase Ib /​ Regorafenib With Conventional Chemotherapy/​Newly Diagnosed Patients/​ Multimetastatic Ewing Sarcoma
Protocol ID
REGO-EWING
Disease (Sub Disease)
Multimetastatic Ewing Sarcoma
Diagnosis Stage
Newly diagnosed
Location
QLD, WA
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Collaborators
Gustave Roussy, Cancer Campus, Grand Paris
Trial Status
Open
Sites
Perth Children's Hospital
Queensland Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
2 Years to 50 Years
International registry ID's
NCT05830084
Back to Registry
Study Title Phase Ib /​ Regorafenib With Conventional Chemotherapy/​Newly Diagnosed Patients/​ Multimetastatic Ewing Sarcoma
Protocol ID REGO-EWING
Disease (Sub Disease) Multimetastatic Ewing Sarcoma
Diagnosis Stage Newly diagnosed
Location QLD / WA
Sponsor Australian & New Zealand Children's Haematology/Oncology Group
Collaborators Gustave Roussy, Cancer Campus, Grand Paris
Links https://clinicaltrials.gov/study/NCT05830084
Trial Status Open
Trial Open Date 27/03/2023
Sites Perth Children's Hospital / Queensland Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility 2 Years to 50 Years
International registry ID's NCT05830084